Uehara, M.; Nakamura, Y.; Suzuki, T.; Nakano, M.; Takahashi, J.
Efficacy and Safety of Oral Ibandronate versus Intravenous Zoledronic Acid on Bone Metabolism and Bone Mineral Density in Postmenopausal Japanese Women with Osteoporosis. J. Clin. Med. 2021, 10, 5420.
https://doi.org/10.3390/jcm10225420
AMA Style
Uehara M, Nakamura Y, Suzuki T, Nakano M, Takahashi J.
Efficacy and Safety of Oral Ibandronate versus Intravenous Zoledronic Acid on Bone Metabolism and Bone Mineral Density in Postmenopausal Japanese Women with Osteoporosis. Journal of Clinical Medicine. 2021; 10(22):5420.
https://doi.org/10.3390/jcm10225420
Chicago/Turabian Style
Uehara, Masashi, Yukio Nakamura, Takako Suzuki, Masaki Nakano, and Jun Takahashi.
2021. "Efficacy and Safety of Oral Ibandronate versus Intravenous Zoledronic Acid on Bone Metabolism and Bone Mineral Density in Postmenopausal Japanese Women with Osteoporosis" Journal of Clinical Medicine 10, no. 22: 5420.
https://doi.org/10.3390/jcm10225420
APA Style
Uehara, M., Nakamura, Y., Suzuki, T., Nakano, M., & Takahashi, J.
(2021). Efficacy and Safety of Oral Ibandronate versus Intravenous Zoledronic Acid on Bone Metabolism and Bone Mineral Density in Postmenopausal Japanese Women with Osteoporosis. Journal of Clinical Medicine, 10(22), 5420.
https://doi.org/10.3390/jcm10225420
